This week marks your last chance to save up to $350 on your ticket to 5th Genome Editing Therapeutics Summit (formerly known as CRISPR 2.0).
With industry giants like Beam, Editas, Intellia, Mammoth, Nvelop, Prime, ReCode, Tune, Scribe, Vertex and Verve in the room, this summit is your opportunity to forge connections, address critical drug development challenges and fast-track your program into the clinic.
Why attend?
- Advance Your Pipeline: Discover actionable solutions to improve safety, precision, and delivery for your gene editing therapeutics
- Engage with Top Innovators: Join 120+ experts and connect with the minds behind today’s biggest breakthroughs
- Leverage Regulatory Insights: Learn from biopharma strategic leaders to support a smooth IND submission and navigate the latest requirements
To claim your $350 discount, secure your pass by midnight Friday October 8.
Register now or download the full event guide to find out more